2 months Eli Lilly Jumps, Reversing Its Weight-Loss Setback, On A Strong 2025 Outlook Investor's Business Daily
Eli Lilly stock rose Thursday despite lighter-than-expected sales of its weight-loss and diabetes drugs Zepbound and Mounjaro.
The post Eli Lilly Jumps, Reversing Its Weight-Loss Setback, On A Strong 2025 Outlook appeared first on Investor's Busin…